Overview
Location
Canada, Montreal (06), Westmount
Employees
1-10
Investment Type
Venture Capital
Investment Stage
Pre-Seed; Seed; Series A
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 6, 2018 | Yaletown Congratulates the Stream 2 Recipients of VCCI | We are proud that Sophie Gupta, Principal with our Innovation Growth Fund, participated in a panel discussion of experts as part of the Canadian government’s announcement of the recipients of Stream 2 of the Venture Capital Catalyst Initiat... |
| Dec 7, 2017 | Term Sheet — Thursday December 7 | GOING GLOBAL Good morning again from Guangzhou, China. Paid Content Securing the enterprise without boundaries From ExtraHop “The backlash against globalization happens because many people feel left behind,” he said. “Closing our doors will... |
| Dec 7, 2017 | Canada's AmorChem launches $44.2M life science fund; Neon adds $36M, Merck partnership in neoantigen drive; CRISPR Therapeutics files a CTA | → Canadian VC firm AmorChem Group has raised $44.2 million for its second life science fund. Backed by LPs including the Québec government, Montreal’s Fonds de solidarité FTQ, and Merck, the new fund is meant to fuel seed-st... |
| Dec 6, 2017 | AmorChem II Ventures Launches Venture Capital Fund Focused on Seed-Stage Biotech | Montreal, Canada-based AmorChem II Ventures, Inc., has launched a life sciences venture capital fund specialized in seed-stage biotechnology investing. AmorChem II Fund L.P., has an initial capitalization of $44.2m and is backed by the Québ... |
| Dec 6, 2017 | AmorChem closes second early-stage biotech fund at $44.2 mln | |
| Dec 6, 2017 | Quebec's Amorchem sets up $44M+ life sciences VC | Amorchem II Ventures launched its second venture capital fund with $44.2 million in backing from the likes of the Quebec government and Merck. This brings the total managed by the AmorChem Group to $86 million. Geared toward seed-stage inve... |
| Dec 6, 2017 | Quebec's Amorchem sets up $44M+ life sciences VC W h i t e p a p e r Weighing the Costs: | Amorchem II Ventures launched its second venture capital fund with $44.2 million in backing from the likes of the Quebec government and Merck. This brings the total managed by the AmorChem Group to $86 million. Sponsored by Agilent Technolo... |
| Feb 18, 2011 | AmorChem Receives $6.8M Investment from Merck Canada | AmorChem, a Quebec, Canada-based life sciences venture capital fund, received a $6.8m investment from Merck Canada. AmorChem, which was established by the Quebec government, Fonds de solidarité FTQ and various supporters, plans to invest in... |
Reviews 0
FAQ about AmorChem
What has the press written about AmorChem?
Parsers VC has collected 9 articles mentioning AmorChem, among them “Yaletown Congratulates the Stream 2 Recipients of VCCI” (Nov 6, 2018) and “Term Sheet — Thursday December 7” (Dec 7, 2017).
Is AmorChem still active?
AmorChem is probably closed: its latest activity on Parsers VC dates from Jan 23, 2024.